T. Ronan Kennedy - 06 May 2025 Form 4 Insider Report for cbdMD, Inc. (YCBD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 May 2025, 16:13:33 UTC
Prior SEC filing
30 Sep 2024
Next SEC filing
02 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ T. Ronan Kennedy

Key filing fact

T. Ronan Kennedy filed Form 4 for cbdMD, Inc. (YCBD) on 08 May 2025.

Key facts

  • This page summarizes T. Ronan Kennedy's Form 4 filing for cbdMD, Inc. (YCBD).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 08 May 2025, 16:13.

Change

  • Previous filing in this sequence was filed on 30 Sep 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001826452 Primary reporting owner

Kennedy Thomas Ronan

Relationship
CEO and CFO, Director
Address
2101 WESTINGHOUSE BLVD. SUITE A, CHARLOTTE
Signature
/s/ T. Ronan Kennedy
Signature date
08 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

YCBD transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+67,869
Change %
+1023%
Price
Shares after
74,501
Date
06 May 2025
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

YCBD transaction Derivative

8% Series A Cumulative Convertible Preferred Stock

Conversion of derivative security

Transaction value
Shares
-41,765
Change %
-100%
Price
Shares after
0
Date
06 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
67,869
Exercise price
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") automatically converted into shares of common stock without any action on the part of the Reporting Person. The automatic conversion converts each share of the Preferred Stock into thirteen shares of the Company's common stock on May 6, 2025 at 4:01 p.m. Eastern Time.

Footnote F2

The price gives effect to the one-for-8 reverse stock split of the Company's issued and outstanding shares of common stock, effective May 6, 2025 at 4:02 p.m. Eastern Time.

Footnote F3

Open market purchases.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .